An Overview of the Company Supriya Lifescience, a Mumbai-based pharmaceutical company, has filed a draft red herring prospectus (DRHP) with capital markets regulator SEBI in order to launch an initial public offering (IPO). The firm intends to raise Rs. 1,200 crores from the primary sector. The IPO consists of a fresh issue of shares worth …